In vivo activation of transferred regulatory T cells specific for third‐party exogenous antigen controls GVH disease in mice

Treg cells hold enormous promise for therapeutic application in GVH disease, a lethal complication of allogeneic HSC transplantation. Mouse studies showed that donor‐derived recipient‐specific Treg (rsTreg) cells are far more efficient than polyclonal Treg cells in suppressing GVH disease. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Gaëlle H., Grégoire, Sylvie, Landau, Dan A., Pilon, Caroline, Grinberg‐Bleyer, Yenkel, Charlotte, Frédéric, Mège, Jean‐Pierre, Chatenoud, Lucienne, Salomon, Benoît L., Cohen, José L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Highlights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738555/
https://www.ncbi.nlm.nih.gov/pubmed/23765389
http://dx.doi.org/10.1002/eji.201343449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738555/
https://www.ncbi.nlm.nih.gov/pubmed/23765389
http://dx.doi.org/10.1002/eji.201343449

Ejemplares similares